Pediatric Drugs and Vaccines Market Report

Global Pediatric Drugs and Vaccines Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Dec 31, 2020
  • PAGES：185
  • REPORT CODE：GMM604648
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pediatric Drugs and Vaccines is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period. The research provides insights for the global Pediatric Drugs and Vaccines market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Pediatric Drugs and Vaccines industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Pediatric Drugs and Vaccines Market Segmentations:

    By Players:

    • Janssen Biologics BV (USA)

    • AstraZeneca Plc (UK)

    • F Hoffmann-La Roche Ltd (Switzerland)

    • Novo Nordisk A/S (Denmark)

    • Shire Pharmaceuticals Group Plc (UK)

    • Shionogi Inc (USA)

    • GlaxoSmithKline plc (UK)

    • Abbott Laboratories (USA)

    • Sanofi SA (France)

    • Novartis AG (Switzerland)

    • Bristol-Myers Squibb Company (USA)

    • Allergan, Inc (USA)

    • Actelion Pharmaceuticals

    • Boehringer Ingelheim GmbH (Germany)

    • Pfizer, Inc (USA)

    • Eli Lilly and Company (USA)

    • Amgen, Inc (USA)

    • Merck & Co, Inc (USA)

    • Genentech, Inc (USA)

    By Types:

    • Diphtheria

    • Influenza

    • Hepatitis

    • Pneumococcal Diseases

    • Meningococcal Diseases

    • Mumps

    • Others

    By End-User:

    • Newborn

    • Infant

    • Child

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pediatric Drugs and Vaccines Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Diphtheria from 2014 to 2026

      • 1.3.2 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Influenza from 2014 to 2026

      • 1.3.3 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Hepatitis from 2014 to 2026

      • 1.3.4 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Pneumococcal Diseases from 2014 to 2026

      • 1.3.5 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Meningococcal Diseases from 2014 to 2026

      • 1.3.6 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Mumps from 2014 to 2026

      • 1.3.7 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Newborn from 2014 to 2026

      • 1.4.2 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Infant from 2014 to 2026

      • 1.4.3 Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Child from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Pediatric Drugs and Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pediatric Drugs and Vaccines Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pediatric Drugs and Vaccines by Major Types

      • 3.4.1 Pediatric Drugs and Vaccines Market Size and Growth Rate of Diphtheria

      • 3.4.2 Pediatric Drugs and Vaccines Market Size and Growth Rate of Influenza

      • 3.4.3 Pediatric Drugs and Vaccines Market Size and Growth Rate of Hepatitis

      • 3.4.4 Pediatric Drugs and Vaccines Market Size and Growth Rate of Pneumococcal Diseases

      • 3.4.5 Pediatric Drugs and Vaccines Market Size and Growth Rate of Meningococcal Diseases

      • 3.4.6 Pediatric Drugs and Vaccines Market Size and Growth Rate of Mumps

      • 3.4.7 Pediatric Drugs and Vaccines Market Size and Growth Rate of Others

    4 Segmentation of Pediatric Drugs and Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pediatric Drugs and Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pediatric Drugs and Vaccines in Newborn

      • 4.4.2 Market Size and Growth Rate of Pediatric Drugs and Vaccines in Infant

      • 4.4.3 Market Size and Growth Rate of Pediatric Drugs and Vaccines in Child

    5 Market Analysis by Major Regions

    • 5.1 Global Pediatric Drugs and Vaccines Production Analysis by Major Regions

    • 5.2 Global Pediatric Drugs and Vaccines Consumption Analysis by Major Regions

    • 5.3 Global Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

    6 Product Commodity of Pediatric Drugs and Vaccines Market in Major Countries

    • 6.1 Top 5 Export Countries in Pediatric Drugs and Vaccines market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pediatric Drugs and Vaccines market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Pediatric Drugs and Vaccines Landscape Analysis

    • 7.1 North America Pediatric Drugs and Vaccines Landscape Analysis by Major Types

    • 7.2 North America Pediatric Drugs and Vaccines Landscape Analysis by Major End-Users

    • 7.3 North America Pediatric Drugs and Vaccines Landscape Analysis by Major Countries

      • 7.3.1 United States Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 7.3.2 Canada Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 7.3.3 Mexico Pediatric Drugs and Vaccines Market Volume and Growth Rate

    8 Europe Pediatric Drugs and Vaccines Landscape Analysis

    • 8.1 Europe Pediatric Drugs and Vaccines Landscape Analysis by Major Types

    • 8.2 Europe Pediatric Drugs and Vaccines Landscape Analysis by Major End-Users

    • 8.3 Europe Pediatric Drugs and Vaccines Landscape Analysis by Major Countries

      • 8.3.1 Germany Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.2 UK Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.3 France Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.4 Italy Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.6 Spain Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.7 Belgium Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.8 Poland Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.9 Russia Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 8.3.10 Turkey Pediatric Drugs and Vaccines Market Volume and Growth Rate

    9 Asia Pacific Pediatric Drugs and Vaccines Landscape Analysis

    • 9.1 Asia Pacific Pediatric Drugs and Vaccines Landscape Analysis by Major Types

    • 9.2 Asia Pacific Pediatric Drugs and Vaccines Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Pediatric Drugs and Vaccines Landscape Analysis by Major Countries

      • 9.3.1 China Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 9.3.2 Japan Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 9.3.4 India Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 9.3.6 South Korea Pediatric Drugs and Vaccines Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Pediatric Drugs and Vaccines Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Pediatric Drugs and Vaccines Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Pediatric Drugs and Vaccines Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Pediatric Drugs and Vaccines Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 10.3.2 Brazil Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 10.3.3 Nigeria Pediatric Drugs and Vaccines Market Volume and Growth Rate

      • 10.3.4 South Africa Pediatric Drugs and Vaccines Market Volume and Growth Rate 

      • 10.3.5 Argentina Pediatric Drugs and Vaccines Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Janssen Biologics BV (USA)

      • 11.1.1 Janssen Biologics BV (USA) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 AstraZeneca Plc (UK)

      • 11.2.1 AstraZeneca Plc (UK) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 F Hoffmann-La Roche Ltd (Switzerland)

      • 11.3.1 F Hoffmann-La Roche Ltd (Switzerland) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Novo Nordisk A/S (Denmark)

      • 11.4.1 Novo Nordisk A/S (Denmark) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Shire Pharmaceuticals Group Plc (UK)

      • 11.5.1 Shire Pharmaceuticals Group Plc (UK) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Shionogi Inc (USA)

      • 11.6.1 Shionogi Inc (USA) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 GlaxoSmithKline plc (UK)

      • 11.7.1 GlaxoSmithKline plc (UK) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Abbott Laboratories (USA)

      • 11.8.1 Abbott Laboratories (USA) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Sanofi SA (France)

      • 11.9.1 Sanofi SA (France) Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Novartis AG (Switzerland)

      • 11.10.1 Novartis AG (Switzerland) Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Bristol-Myers Squibb Company (USA)

      • 11.11.1 Bristol-Myers Squibb Company (USA) Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Allergan, Inc (USA)

      • 11.12.1 Allergan, Inc (USA) Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Actelion Pharmaceuticals

      • 11.13.1 Actelion Pharmaceuticals Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Boehringer Ingelheim GmbH (Germany)

      • 11.14.1 Boehringer Ingelheim GmbH (Germany) Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Pfizer, Inc (USA)

      • 11.15.1 Pfizer, Inc (USA) Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Eli Lilly and Company (USA)

      • 11.16.1 Eli Lilly and Company (USA) Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Amgen, Inc (USA)

      • 11.17.1 Amgen, Inc (USA) Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Merck & Co, Inc (USA)

      • 11.18.1 Merck & Co, Inc (USA) Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Genentech, Inc (USA)

      • 11.19.1 Genentech, Inc (USA) Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 80 Figures and 195 Tables)

    • Figure Product Picture

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Diphtheria from 2014 to 2026

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Influenza from 2014 to 2026

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Hepatitis from 2014 to 2026

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Pneumococcal Diseases from 2014 to 2026

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Meningococcal Diseases from 2014 to 2026

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Mumps from 2014 to 2026

    • Figure Pediatric Drugs and Vaccines Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Newborn from 2014 to 2026

    • Figure Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Infant from 2014 to 2026

    • Figure Global Pediatric Drugs and Vaccines Market Size and Growth Rate of Child from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Pediatric Drugs and Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pediatric Drugs and Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pediatric Drugs and Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pediatric Drugs and Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Pediatric Drugs and Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diphtheria

    • Figure Market Size and Growth Rate of Influenza

    • Figure Market Size and Growth Rate of Hepatitis

    • Figure Market Size and Growth Rate of Pneumococcal Diseases

    • Figure Market Size and Growth Rate of Meningococcal Diseases

    • Figure Market Size and Growth Rate of Mumps

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pediatric Drugs and Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pediatric Drugs and Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Newborn

    • Figure Market Size and Growth Rate of Infant

    • Figure Market Size and Growth Rate of Child

    • Table Global Pediatric Drugs and Vaccines Production by Major Regions

    • Table Global Pediatric Drugs and Vaccines Production Share by Major Regions

    • Figure Global Pediatric Drugs and Vaccines Production Share by Major Regions in 2014

    • Figure Global Pediatric Drugs and Vaccines Production Share by Major Regions in 2018

    • Figure Global Pediatric Drugs and Vaccines Production Share by Major Regions in 2026

    • Table Global Pediatric Drugs and Vaccines Consumption by Major Regions

    • Table Global Pediatric Drugs and Vaccines Consumption Share by Major Regions

    • Figure Global Pediatric Drugs and Vaccines Consumption Share by Major Regions in 2014

    • Figure Global Pediatric Drugs and Vaccines Consumption Share by Major Regions in 2018

    • Figure Global Pediatric Drugs and Vaccines Consumption Share by Major Regions in 2026

    • Table North America Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

    • Table Europe Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pediatric Drugs and Vaccines market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Pediatric Drugs and Vaccines Consumption by Types from 2014 to 2026

    • Table North America Pediatric Drugs and Vaccines Consumption Share by Types from 2014 to 2026

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by Types in 2014

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by Types in 2018

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by Types in 2026

    • Table North America Pediatric Drugs and Vaccines Consumption by End-Users from 2014 to 2026

    • Table North America Pediatric Drugs and Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by End-Users in 2014

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by End-Users in 2018

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by End-Users in 2026

    • Table North America Pediatric Drugs and Vaccines Consumption by Major Countries from 2014 to 2026

    • Table North America Pediatric Drugs and Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2014

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2018

    • Figure North America Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2026

    • Figure United States Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Pediatric Drugs and Vaccines Consumption by Types from 2014 to 2026

    • Table Europe Pediatric Drugs and Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by Types in 2014

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by Types in 2018

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by Types in 2026

    • Table Europe Pediatric Drugs and Vaccines Consumption by End-Users from 2014 to 2026

    • Table Europe Pediatric Drugs and Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by End-Users in 2014

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by End-Users in 2018

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by End-Users in 2026

    • Table Europe Pediatric Drugs and Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Europe Pediatric Drugs and Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2014

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2018

    • Figure Europe Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2026

    • Figure Germany Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure France Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Pediatric Drugs and Vaccines Consumption by Types from 2014 to 2026

    • Table Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Types in 2014

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Types in 2018

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Types in 2026

    • Table Asia Pacific Pediatric Drugs and Vaccines Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Pediatric Drugs and Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by End-Users in 2014

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by End-Users in 2018

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by End-Users in 2026

    • Table Asia Pacific Pediatric Drugs and Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2026

    • Figure China Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandPediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure India Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Pediatric Drugs and Vaccines Consumption Share by Major Countries in 2026

    • Figure GCC Countries Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Pediatric Drugs and Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Janssen Biologics BV (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Biologics BV (USA)

    • Figure Sales and Growth Rate Analysis of Janssen Biologics BV (USA)

    • Figure Revenue and Market Share Analysis of Janssen Biologics BV (USA)

    • Table Product and Service Introduction of Janssen Biologics BV (USA)

    • Table Company Profile and Development Status of AstraZeneca Plc (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca Plc (UK)

    • Figure Sales and Growth Rate Analysis of AstraZeneca Plc (UK)

    • Figure Revenue and Market Share Analysis of AstraZeneca Plc (UK)

    • Table Product and Service Introduction of AstraZeneca Plc (UK)

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd (Switzerland)

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd (Switzerland)

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd (Switzerland)

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd (Switzerland)

    • Table Company Profile and Development Status of Novo Nordisk A/S (Denmark)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S (Denmark)

    • Figure Sales and Growth Rate Analysis of Novo Nordisk A/S (Denmark)

    • Figure Revenue and Market Share Analysis of Novo Nordisk A/S (Denmark)

    • Table Product and Service Introduction of Novo Nordisk A/S (Denmark)

    • Table Company Profile and Development Status of Shire Pharmaceuticals Group Plc (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire Pharmaceuticals Group Plc (UK)

    • Figure Sales and Growth Rate Analysis of Shire Pharmaceuticals Group Plc (UK)

    • Figure Revenue and Market Share Analysis of Shire Pharmaceuticals Group Plc (UK)

    • Table Product and Service Introduction of Shire Pharmaceuticals Group Plc (UK)

    • Table Company Profile and Development Status of Shionogi Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi Inc (USA)

    • Figure Sales and Growth Rate Analysis of Shionogi Inc (USA)

    • Figure Revenue and Market Share Analysis of Shionogi Inc (USA)

    • Table Product and Service Introduction of Shionogi Inc (USA)

    • Table Company Profile and Development Status of GlaxoSmithKline plc (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc (UK)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc (UK)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc (UK)

    • Table Product and Service Introduction of GlaxoSmithKline plc (UK)

    • Table Company Profile and Development Status of Abbott Laboratories (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories (USA)

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories (USA)

    • Figure Revenue and Market Share Analysis of Abbott Laboratories (USA)

    • Table Product and Service Introduction of Abbott Laboratories (USA)

    • Table Company Profile and Development Status of Sanofi SA (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA (France)

    • Figure Sales and Growth Rate Analysis of Sanofi SA (France)

    • Figure Revenue and Market Share Analysis of Sanofi SA (France)

    • Table Product and Service Introduction of Sanofi SA (France)

    • Table Company Profile and Development Status of Novartis AG (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

    • Table Product and Service Introduction of Novartis AG (Switzerland)

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company (USA)

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company (USA)

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company (USA)

    • Table Product and Service Introduction of Bristol-Myers Squibb Company (USA)

    • Table Company Profile and Development Status of Allergan, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Allergan, Inc (USA)

    • Figure Revenue and Market Share Analysis of Allergan, Inc (USA)

    • Table Product and Service Introduction of Allergan, Inc (USA)

    • Table Company Profile and Development Status of Actelion Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actelion Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Actelion Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Actelion Pharmaceuticals

    • Table Product and Service Introduction of Actelion Pharmaceuticals

    • Table Company Profile and Development Status of Boehringer Ingelheim GmbH (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH (Germany)

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH (Germany)

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH (Germany)

    • Table Product and Service Introduction of Boehringer Ingelheim GmbH (Germany)

    • Table Company Profile and Development Status of Pfizer, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc (USA)

    • Figure Revenue and Market Share Analysis of Pfizer, Inc (USA)

    • Table Product and Service Introduction of Pfizer, Inc (USA)

    • Table Company Profile and Development Status of Eli Lilly and Company (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company (USA)

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company (USA)

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company (USA)

    • Table Product and Service Introduction of Eli Lilly and Company (USA)

    • Table Company Profile and Development Status of Amgen, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Amgen, Inc (USA)

    • Figure Revenue and Market Share Analysis of Amgen, Inc (USA)

    • Table Product and Service Introduction of Amgen, Inc (USA)

    • Table Company Profile and Development Status of Merck & Co, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc (USA)

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc (USA)

    • Table Product and Service Introduction of Merck & Co, Inc (USA)

    • Table Company Profile and Development Status of Genentech, Inc (USA)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc (USA)

    • Figure Sales and Growth Rate Analysis of Genentech, Inc (USA)

    • Figure Revenue and Market Share Analysis of Genentech, Inc (USA)

    • Table Product and Service Introduction of Genentech, Inc (USA)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US